We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$773M 5.22%
3,224,439
+26,804
+0.8% +$6.43M
AAPL icon
2
Apple
AAPL
$4.81T
$572M 3.86%
4,403,281
-223,327
-5% -$31.9M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$366M 2.47%
4,147,775
+2,501
+0.1% +$238K
MRK icon
4
Merck
MRK
$312B
$356M 2.4%
3,205,692
-272,866
-8% -$27.9M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$70.5B
$276M 1.86%
382,968
-19,553
-5% -$14.4M
UNH icon
6
UnitedHealth
UNH
$396B
$261M 1.76%
492,275
+8,357
+2% +$4.43M
AMGN icon
7
Amgen
AMGN
$198B
$257M 1.74%
979,786
+13,861
+1% +$3.72M
DHR icon
8
Danaher
DHR
$127B
$251M 1.69%
1,065,241
+65,537
+7% +$15.2M
TMO icon
9
Thermo Fisher Scientific
TMO
$195B
$242M 1.63%
439,194
+11,330
+3% +$6M
PG icon
10
Procter & Gamble
PG
$345B
$224M 1.51%
1,478,925
-102,184
-6% -$14.3M
LLY icon
11
Eli Lilly
LLY
$1.05T
$197M 1.33%
537,869
-11,094
-2% -$3.93M
V icon
12
Visa
V
$677B
$164M 1.1%
788,290
+46,249
+6% +$9.33M
GILD icon
13
Gilead Sciences
GILD
$162B
$140M 0.95%
1,634,507
-376,397
-19% -$29.8M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.22T
$140M 0.94%
1,576,052
+71,224
+5% +$6.8M
VRTX icon
15
Vertex Pharmaceuticals
VRTX
$122B
$135M 0.91%
469,145
-15,394
-3% -$4.69M
MA icon
16
Mastercard
MA
$476B
$125M 0.85%
360,332
+8,999
+3% +$2.96M
DAR icon
17
Darling Ingredients
DAR
$10.2B
$125M 0.84%
1,991,006
+591,099
+42% +$41.7M
JNJ icon
18
Johnson & Johnson
JNJ
$603B
$122M 0.82%
691,056
+195,274
+39% +$33.7M
BAC icon
19
Bank of America
BAC
$430B
$118M 0.8%
3,576,715
-1,218
-0% -$42K
AMZN icon
20
Amazon
AMZN
$2.66T
$118M 0.79%
1,401,655
+219,722
+19% +$21.7M
ABT icon
21
Abbott
ABT
$174B
$115M 0.77%
1,044,730
-92,209
-8% -$9.55M
MELI icon
22
Mercado Libre
MELI
$92.4B
$107M 0.73%
127,002
+48,520
+62% +$43.2M
TSLA icon
23
Tesla
TSLA
$1.42T
$107M 0.72%
869,131
+152,046
+21% +$28.8M
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
$104M 0.7%
807,872
+67,844
+9% +$8.76M
HD icon
25
Home Depot
HD
$331B
$103M 0.69%
325,359
+57,248
+21% +$17.4M
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.